FDCDDQ
TGTX icon

Federation des caisses Desjardins du Quebec’s TG Therapeutics TGTX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Hold
200
– – ﹤0.01% 2382
2026
Q1 		$6.64K Buy
+200
New +$5.96K ﹤0.01% 2430
2024
Q2 		– Sell
-40
Closed -$608 – 2566
2024
Q1 		$608 Buy
+40
New +$637 ﹤0.01% 2225
2018
Q1 		– Sell
-1,700
Closed -$13.9K – 2216
2017
Q4 		$13.9K Buy
+1,700
New +$14.9K ﹤0.01% 1652

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's TGTX Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec held its TG Therapeutics (TGTX) position steady in Q2 2026 at 200 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

Federation des caisses Desjardins du Quebec first reported a position in TGTX in Q4 2017 and has held it in 4 quarters since. The position peaked at $13.9K in Q4 2017. 431 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 200 shares of TG Therapeutics worth $11K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec left its TG Therapeutics share count unchanged in Q2 2026.
  • TG Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2382 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in TG Therapeutics in Q4 2017 and has held it in 4 quarters since.
  • Federation des caisses Desjardins du Quebec's TG Therapeutics position peaked at $13.9K in Q4 2017.
  • 431 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.